aTyr Pharma | LIFE - Capital Ordinário





Capital Ordinário Alterar Data
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Ardelyx USD 246.97M 2.62M 2026-03
aTyr Pharma USD 62.99M 46.35M 2026-03
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cipla INR 807.78M 17K 2026-03
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1000 2026-03
CSL USD 482.13M 93.87M 2025-12
Curis USD 2M 10.93M 2026-03
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
Grifols EUR 680.58M 846.11K 2025-12
Lakefront Biotherapeutics EUR 65.66M 242K 2026-06
Novartis USD 1.9B 7.38M 2026-06
Roche Holding CHF 796.77M 1.15M 2026-06
United Therapeutics USD 42.68M 521K 2026-06